{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:05:16Z","timestamp":1785355516383,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202240152"],"award-info":[{"award-number":["202240152"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20254Y0062"],"award-info":[{"award-number":["20254Y0062"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23Y11907400"],"award-info":[{"award-number":["23Y11907400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371923"],"award-info":[{"award-number":["82371923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502281"],"award-info":[{"award-number":["82502281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171897"],"award-info":[{"award-number":["82171897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772405"],"award-info":[{"award-number":["2025M772405"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.acra.2026.03.052","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:50:41Z","timestamp":1776801041000},"page":"3232-3247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRI-Derived Intra- and Peritumoral Heterogeneity for Predicting Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Fei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.acra.2026.03.052_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib3","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.acra.2026.03.052_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2025.10.020","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: the 2025 update","volume":"84","author":"Reig","year":"2025","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.acra.2026.03.052_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000530495","article-title":"Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition)","volume":"12","author":"Zhou","year":"2023","journal-title":"Liver Cancer"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib6","article-title":"Association of sustained response duration with survival after conventional transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"1","author":"Zhang","year":"2018","journal-title":"JAMA Net\u00a0Open"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jhep.2015.01.022","article-title":"Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma","volume":"62","author":"Kim","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000485471","article-title":"Patient selection for transarterial chemoembolization in hepatocellular carcinoma: importance of benefit\/risk assessment","volume":"7","author":"Piscaglia","year":"2018","journal-title":"Liver Cancer"},{"issue":"3","key":"10.1016\/j.acra.2026.03.052_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1148\/radiol.2021202289","article-title":"Lack of response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: abandon or repeat?","volume":"298","author":"Chen","year":"2021","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib10","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/hep.26256","article-title":"The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"57","author":"Sieghart","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000365993","article-title":"Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization","volume":"87","author":"Ogasawara","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.acra.2026.03.052_bib12","first-page":"53","article-title":"ONCOhabitats: a system for glioblastoma heterogeneity assessment through MRI","volume":"128","author":"Juan-Albarrac\u00cdn","year":"2019","journal-title":"Int J\u00a0Med\u00a0Inform"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib13","article-title":"MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer","volume":"308","author":"Shi","year":"2023","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.acra.2026.03.052_bib14","first-page":"845","article-title":"A pilot study of multidimensional diffusion MRI for assessment of tissue heterogeneity in prostate cancer","volume":"56","author":"Langbein","year":"2021","journal-title":"Invest\u00a0Radiol"},{"issue":"7","key":"10.1016\/j.acra.2026.03.052_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000705","article-title":"Mechanisms of tumor heterogeneity in TACE-resistant liver cancer: insights from single-cell and whole-exome sequencing","volume":"9","author":"Liu","year":"2025","journal-title":"Hepatology Commun"},{"issue":"2","key":"10.1016\/j.acra.2026.03.052_bib16","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230457","article-title":"Identifying proliferative hepatocellular carcinoma at pretreatment CT: implications for therapeutic outcomes after transarterial chemoembolization","volume":"308","author":"Bao","year":"2023","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.acra.2026.03.052_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1148\/radiol.2021202289","article-title":"Lack of response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: abandon or repeat?","volume":"298","author":"Chen","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000530950","article-title":"Radiologic patterns determine the outcomes of initial and subsequent transarterial chemoembolization in intermediate-stage hepatocellular carcinoma","volume":"13","author":"Hung","year":"2024","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.acra.2026.03.052_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","article-title":"mRECIST for HCC: performance and novel refinements","volume":"72","author":"Llovet","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib20","article-title":"MRI-based intra-and peritumoral heterogeneity in hepatocellular carcinoma for microvascular invasion prediction and prognostic risk stratification","volume":"7","author":"Zhang","year":"2025","journal-title":"Radiology\u00a0Imaging Cancer"},{"issue":"21","key":"10.1016\/j.acra.2026.03.052_bib21","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"Van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.acra.2026.03.052_bib22","article-title":"A unified approach to interpreting model predictions","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv\u00a0Neural Info\u00a0Proc\u00a0Syst"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib23","first-page":"176","article-title":"Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features","volume":"22","author":"Li","year":"2022","journal-title":"BMC Med\u00a0Imaging"},{"issue":"2","key":"10.1016\/j.acra.2026.03.052_bib24","first-page":"533","article-title":"Artificial Intelligence and machine learning predicting transarterial chemoembolization outcomes: a systematic review","volume":"70","author":"Cho","year":"2025","journal-title":"Digest\u00a0Dis\u00a0Sci"},{"issue":"8","key":"10.1016\/j.acra.2026.03.052_bib25","first-page":"1099","article-title":"Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"129","author":"Deng","year":"2024","journal-title":"La Radiol\u00a0Med"},{"key":"10.1016\/j.acra.2026.03.052_bib26","first-page":"1097","article-title":"Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus Immunotherapy and targeted therapy in HCC","volume":"10","author":"Jin","year":"2025","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.acra.2026.03.052_bib27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.acra.2026.03.052_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s00330-021-08166-4","article-title":"Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging","volume":"32","author":"Kim","year":"2022","journal-title":"European Radiology"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13244-025-01956-0","article-title":"Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma","volume":"16","author":"Shen","year":"2025","journal-title":"Insights into imaging"},{"issue":"11","key":"10.1016\/j.acra.2026.03.052_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100444","article-title":"Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization","volume":"2","author":"Boldanova","year":"2021","journal-title":"Cell Reports Medicine"},{"issue":"11","key":"10.1016\/j.acra.2026.03.052_bib31","first-page":"6451","article-title":"MRI-Based quantification of intratumoral heterogeneity predicts response in hepatocellular carcinoma treated with atezolizumab-bevacizumab and TACE\/HAIC","volume":"32","author":"Yan","year":"2025","journal-title":"Acad\u00a0Radiol"},{"issue":"7467","key":"10.1016\/j.acra.2026.03.052_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.acra.2026.03.052_bib33","first-page":"6083","article-title":"Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models","volume":"20","author":"Song","year":"2014","journal-title":"Clin\u00a0Cancer Res"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib34","article-title":"Amount of ascites impacts survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization advocating for volumetric assessment","volume":"14","author":"M\u00dcller","year":"2024","journal-title":"Sci\u00a0Rep"},{"issue":"2","key":"10.1016\/j.acra.2026.03.052_bib35","first-page":"289","article-title":"Tumor enhancement and heterogeneity are associated with treatment response to drug-eluting bead chemoembolization for hepatocellular carcinoma","volume":"41","author":"Reis","year":"2017","journal-title":"J\u00a0Comp\u00a0Assisted Tomography"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40644-022-00477-z","article-title":"Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACE","volume":"22","author":"Chai","year":"2022","journal-title":"Cancer Imaging"},{"issue":"2","key":"10.1016\/j.acra.2026.03.052_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000367754","article-title":"Tumor heterogeneity in hepatocellular carcinoma: facing the challenges","volume":"5","author":"Lu","year":"2016","journal-title":"Liver Cancer"},{"issue":"5","key":"10.1016\/j.acra.2026.03.052_bib38","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.24246","article-title":"Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (< 5 cm) hepatocellular carcinomas","volume":"53","author":"Golfieri","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib39","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1186\/s12885-023-11491-0","article-title":"Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib40","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.acra.2026.03.052_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000512028","article-title":"Clinical-radiomic analysis for pretreatment prediction of objective response to first transarterial chemoembolization in hepatocellular carcinoma","volume":"10","author":"Chen","year":"2021","journal-title":"Liver Cancer"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226002564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226002564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:25:23Z","timestamp":1785353123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226002564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1076633226002564"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.03.052","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-Derived Intra- and Peritumoral Heterogeneity for Predicting Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.03.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}